人血制品
CN → US| HS Code | Tariff Rate | Origin | Destination | Doc |
|---|---|---|---|---|
| 3001900190 | 0.0% | CN | US | Official Doc |
| 3001200000 | 10.0% | CN | US | Official Doc |
| 3002120010 | 10.0% | CN | US | Official Doc |
| 3002120090 | 10.0% | CN | US | Official Doc |
| 3002200000 | 0.0% | CN | US | Official Doc |
| 3004901000 | 10.0% | CN | US | Official Doc |
AI Analysis
🩸 Human Blood Products (Human Blood and Blood Fractions for Therapeutic, Prophylactic or Diagnostic Uses)
🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Import Strategy
📌 One, Product Definition & Classification: What Exactly Are Human Blood Products?
Human blood products are biological substances derived from human blood, prepared for therapeutic, prophylactic, or diagnostic purposes. These include:
- Whole human blood (for transfusion or processing)
- Human blood plasma (the liquid component of blood, used to produce clotting factors, immunoglobulins, etc.)
- Antisera and other blood fractions (e.g., albumin, immunoglobulins, clotting factors)
- Modified immunological products (e.g., recombinant or biotechnologically processed blood-derived products)
⚠️ Key Distinction:
- If the product is raw or minimally processed blood → classified under 3002.20.00.00
- If it's purified plasma, antisera, or immunoglobulins → classified under 3002.12.00.10 / 3002.12.00.90
📦 Two, HS Code Classification Details (2026 Latest Tariff Authority Match)
| HS Code | Product Description | Applicable Use Cases | Processing Level |
|---|---|---|---|
3002.12.00.10 |
Antisera, other blood fractions, and immunological products: Human blood plasma | Plasma-derived therapies, IVIG, clotting factor production, vaccine development | Highly processed, purified |
3002.12.00.90 |
Antisera, other blood fractions, and immunological products: Other (not plasma) | Immunoglobulins, albumin, coagulation factors, diagnostic reagents | Processed but not plasma-specific |
3002.20.00.00 |
Human or animal blood prepared for therapeutic, prophylactic, or diagnostic uses; antisera and other blood fractions | Whole blood, fresh frozen plasma, blood for transfusion, raw blood components | Minimal processing, raw or semi-processed |
🔍 Critical Note:
- Plasma-only products (e.g., for IVIG production) → must be declared under 3002.12.00.10
- Whole blood or fresh blood → 3002.20.00.00
- Misclassification leads to penalties, delays, or seizure
💰 Three, 2026 Latest Tariff Rate Breakdown (With Additional Taxes & Policy Rules)
✅ Applicable Country: United States (US)
✅ Origin: China (CN) or Other Countries
✅ Effective Date: 2025–2026 (as per current tariff schedules)
🎯 1. 3002.12.00.10 — Human Blood Plasma
| Item | Details |
|---|---|
| Base Tariff Rate | 0.0% (ad valorem) |
| USITC Additional Duty | 0.0% |
| IEEPA Additional Duty | 0.0% |
| Total Tax Rate | 0.0% |
| Tax Calculation | CIF Value × 0.0% |
| De Minimis Threshold | ✅ Yes (eligible for de minimis exemption) |
| Legal Basis Path | USITC:3002.12.00.10 → FOOTNOTE:9903.88.01 → IEEPA:9903.01.25 |
📌 Explanation:
- Human blood plasma is exempt from additional tariffs under current US trade policy. - Despite being a high-value biological product, no Section 301 or IEEPA duties apply. - Zero duty applies even if imported from China.
🎯 2. 3002.12.00.90 — Other Antisera, Blood Fractions, Immunological Products
| Item | Details |
|---|---|
| Base Tariff Rate | 0.0% |
| USITC Additional Duty | 0.0% |
| IEEPA Additional Duty | 0.0% |
| Total Tax Rate | 0.0% |
| Tax Calculation | CIF Value × 0.0% |
| De Minimis Threshold | ✅ Yes |
| Legal Basis Path | USITC:3002.12.00.90 → FOOTNOTE:9903.88.01 → IEEPA:9903.01.25 |
📌 Note:
- This includes immunoglobulins, albumin, coagulation factors, and diagnostic blood reagents. - No additional tariffs apply, even if produced in China. - No IEEPA or Section 301 duties are imposed on these medical products.
🎯 3. 3002.20.00.00 — Human Blood for Therapeutic/Prophylactic Uses (Raw/Minimal Processing)
| Item | Details |
|---|---|
| Base Tariff Rate | 0.0% |
| USITC Additional Duty | 0.0% |
| IEEPA Additional Duty | 0.0% |
| Total Tax Rate | 0.0% |
| Tax Calculation | CIF Value × 0.0% |
| De Minimis Threshold | ✅ Yes |
| Legal Basis Path | USITC:3002.20.00.00 → FOOTNOTE:9903.88.01 → IEEPA:9903.01.25 |
📌 Important:
- This code covers whole blood, fresh frozen plasma, and unprocessed blood components. - Despite being a critical medical commodity, it remains tariff-free under current US law. - No special import restrictions apply (subject to FDA/USDA regulations).
🛠️ Four, Customs Clearance Best Practices (Pro Tips to Avoid Delays)
✅ 1. Required Documentation (Must-Have Checklist)
| Document | Required? | Notes |
|---|---|---|
| ✅ Commercial Invoice | ✔️ | Must clearly state: "Human Blood Plasma" or "Therapeutic Blood Fraction" |
| ✅ Bill of Lading / Air Waybill | ✔️ | Include HS Code and product description |
| ✅ FDA Certificate of Product Registration | ✔️ | For blood products, FDA approval is mandatory |
| ✅ Health Certificate (from exporting country) | ✔️ | Issued by national health authority (e.g., EMA, NMPA, MHRA) |
| ✅ Product Specifications & Test Reports | ✔️ | Including viral inactivation, sterility, potency |
| ✅ Certificate of Origin (CO) | ✔️ | If claiming preferential treatment (e.g., USMCA) |
| ✅ Cold Chain Log (if applicable) | ✔️ | For frozen plasma or blood products |
✅ 2. Declaration Best Practices (Pro Tips)
🔥 "Plasma ≠ Whole Blood, Plasma ≠ Antisera – Declare Accurately or Pay the Price!"
| Scenario | Correct HS Code | Common Mistake |
|---|---|---|
| Fresh frozen plasma (FFP) | 3002.12.00.10 |
Misreported as 3002.20.00.00 |
| IVIG (Intravenous Immunoglobulin) | 3002.12.00.90 |
Misclassified as "drug" or "vaccine" |
| Whole blood for transfusion | 3002.20.00.00 |
Incorrectly declared as "plasma" |
| Blood used in diagnostic labs | 3002.12.00.90 |
Reported as "chemical reagent" |
✅ Correct Declaration Example:
"Human Blood Plasma, Fresh Frozen, for IVIG Production, 1000 mL, FDA-Registered, Cold Chain Shipped, Origin: Germany, HS Code: 3002.12.00.10"
✅ 3. Special Cases & Risk Mitigation
| Situation | Recommended Action |
|---|---|
| Importing from China | ✅ No additional tariffs apply → No need to worry about 301/IEEPA duties |
| Using biotech-modified blood products | ✅ Still falls under 3002.12.00.90 — No extra tax |
| Emergency medical supply | ✅ Can request expedited clearance via FDA/Customs Emergency Protocol |
| Reimporting unused blood products | ✅ Requires FDA re-approval; declare under same HS Code |
| Product recalled or expired | ❌ Do not import — may be seized or destroyed |
🌍 Five, Global Market Customs Comparison (2026 Latest)
| Country/Region | Recommended HS Code | Tariff Rate | Certification Required | Notes |
|---|---|---|---|---|
| 🇺🇸 United States | 3002.12.00.10 / 3002.20.00.00 |
0.0% | FDA, Health Certificate | No additional tariffs |
| 🇨🇳 China | 3002.12.00.10 |
5% | NMPA, GMP | No IEEPA duties |
| 🇪🇺 European Union | 3002.12.00.10 |
0% (if CE-certified) | EMA, GDP | No extra duties |
| 🇦🇺 Australia | 3002.12.00.10 |
0% | TGA | No additional taxes |
| 🇯🇵 Japan | 3002.12.00.10 |
0% | PMDA | No tariffs |
📌 Conclusion:
- The U.S. is the most favorable market for human blood products — 0% tariff, no IEEPA/301 duties. - China, EU, Australia, and Japan also offer zero or low tariffs. - No country currently imposes additional tariffs on blood products — a rare exception in medical trade.
📌 Six, Common Mistakes & Risk Warnings (Avoid These!)
❌ Mistake 1: Declaring plasma as whole blood
👉 Result: Incorrect HS Code, risk of seizure, delay, or reclassification → extra cost
❌ Mistake 2: Using generic terms like “blood product” or “biological”
👉 Result: Customs cannot verify classification → request for clarification, delay
❌ Mistake 3: Failing to provide FDA registration or health certificate
👉 Result: Denial of entry, product destruction
❌ Mistake 4: Importing non-therapeutic blood (e.g., for research only)
👉 Result: May be treated as non-medical, subject to stricter rules
✅ Correct Approach:
Always use precise, FDA-recognized terminology:
"Human Blood Plasma, Fresh Frozen, for Therapeutic Use, IVIG Production, FDA-Registered, HS Code: 3002.12.00.10"
🎯 Seven, Final Verdict: Precision Pays Off
🎯 Remember the Golden Rule:
🔹 "Plasma = 3002.12.00.10 | Whole Blood = 3002.20.00.00 | Other Fractions = 3002.12.00.90"
🔹 "No tariffs, no extra duties — even from China!"
📌 Pro Tip:
📞 Apply for a Pre-Clearance Ruling (Advance Ruling) with U.S. Customs if importing large volumes or novel blood products.
🚀 This ensures zero risk of misclassification and smooth, fast clearance.
📣 Act Now!
📞 Contact a specialized biologics customs broker
📄 Provide product specs, FDA docs, and cold chain records
✅ Secure zero-tariff, high-compliance clearance for your human blood products
✨ Expert Advice:
Human blood products are among the few medical goods exempt from trade wars.
Use this to your advantage — declare correctly, pay nothing, deliver life-saving therapies on time!
💼 Your compliance isn’t just legal — it’s lifesaving.
Customer Reviews
About HS Code Classification
The Harmonized System (HS) is an internationally standardized nomenclature developed by the World Customs Organization (WCO) to classify traded products. Over 200 countries use the HS system as the basis for customs tariffs, trade statistics, and import/export regulations.
Each HS code follows a hierarchical structure:
- Chapter (2 digits) — Broad category of goods (e.g., Chapter 84: Machinery and Mechanical Appliances)
- Heading (4 digits) — More specific grouping within the chapter
- Subheading (6 digits) — Internationally standardized breakdown, used by all WCO member countries
- National subdivisions (8-10 digits) — Country-specific extensions for further classification, such as US HTSUS 10-digit codes
Correct HS code classification is essential for smooth customs clearance, accurate duty payment, and compliance with trade regulations. Misclassification can lead to customs delays, overpayment of duties, or penalties.
When importing from CN to US, the applicable tariff rates may include:
- Most-Favored-Nation (MFN) rate — The standard duty rate applied to WTO members
- General rate — Applied to countries without trade agreements
- Trade remedy duties — Additional tariffs such as Section 301 (anti-dumping), Section 232 (national security), or countervailing duties
The information provided on this page is for reference purposes only. For official classification, please consult with your local customs authority or a licensed customs broker.